Healthcare Realty Trust Incorporated (HR)
Healthcare Realty Trust (HR) Q4 FFO Meet Estimates
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.4 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.4 per share a year ago.
Healthcare Realty: Buy This Durable REIT While It's Undervalued
Healthcare Realty Trust remains a compelling value and income play, trading at a forward P/FFO of 10.6 and yielding 5.7%. HR demonstrates robust fundamentals with 5% YoY FFO/share growth, 5.4% same-store NOI growth, and near-record tenant retention at 89%. Favorable demographics and secular demand for outpatient medical space underpin HR's growth, with occupancy and leasing pipelines showing continued strength.
What Makes Healthcare Realty Trust (HR) a New Buy Stock
Healthcare Realty Trust (HR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Healthcare Realty Trust Incorporated (HR) Q3 2025 Earnings Call Transcript
Healthcare Realty Trust Incorporated ( HR ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Ronald M. Hubbard Peter Scott - President, CEO & Director Robert Hull - Executive VP & COO Austen Helfrich - Executive VP & CFO Ryan Crowley - Executive VP & Chief Investment Officer Conference Call Participants Nicholas Yulico - Scotiabank Global Banking and Markets, Research Division Richard Anderson - Cantor Fitzgerald & Co., Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division Robin Haneland - BMO Capital Markets Equity Research Seth Bergey - Citigroup Inc., Research Division Michael Carroll - RBC Capital Markets, Research Division Michael Gorman - BTIG, LLC, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division John Pawlowski - Green Street Advisors, LLC, Research Division Presentation Operator Good morning, and welcome to Healthcare Realty's Third Quarter 2025 Earnings Conference Call.
Compared to Estimates, Healthcare Realty Trust (HR) Q3 Earnings: A Look at Key Metrics
The headline numbers for Healthcare Realty Trust (HR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare Realty Trust (HR) Tops Q3 FFO and Revenue Estimates
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.39 per share a year ago.
Healthcare Realty (HR) Q2 FFO Jumps 8%
Healthcare Realty Trust (HR 7.68%), an owner and operator of medical office buildings, released its second quarter 2025 earnings on July 31, 2025. The results showed Normalized FFO per share at $0.41, exceeding analyst estimates by a wide margin (non-GAAP), while reported GAAP net loss per share was $(0.45).
Healthcare Realty Trust Incorporated (HR) Q2 2025 Earnings Call Transcript
Healthcare Realty Trust Incorporated (NYSE:HR ) Q2 2025 Earnings Conference Call August 1, 2025 9:00 AM ET Company Participants Austen B. Helfrich - Executive VP & CFO Peter A.
Healthcare Realty Trust (HR) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Healthcare Realty Trust (HR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Healthcare Realty Trust (HR) Tops Q2 FFO Estimates
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.38 per share a year ago.
Healthcare Realty Trust: Yield Looks Tempting, But Wait For Execution
Healthcare Realty Trust offers a defensive yield of 7-8% due to price correction, but valuation reflects ongoing rate pressures and merger impacts. Normalized FFO is stabilizing post-merger, but execution on leasing, asset sales, and debt reduction is critical for future re-rating. Dividend coverage is tight, with FAD at 93%, making payouts vulnerable to macro or operational setbacks until asset sales progress.
H&R REIT: Bull Case Remains Intact For 6.7% Yielder
H&R REIT's transformation has slowed down recently. Q1-2025 results were strong though as the strong US dollar boosted NOI. We examine the bull case in light of the large drop in the US Dollar in the last 2 months.
